HEPATITIS – Leaf411

HEPATITIS:

2022
Cannabis Use as a factor of lowered Corpulence in hepatitis C-infected patients: a result of the ANRS CO22 Hepather cohort. (France, 2022, open access, full article) https://jcannabisresearch.biomedcentral.com/track/pdf/10.1186/s42238-022-00138-9.pdf
2019
Endocannabinoid modulation of inflammatory hyperalgesia in the IFN-α mouse model of depression. (Ireland, abstract, 2019) https://www.sciencedirect.com/science/article/abs/pii/S0889159119306063?via%3Dihub
No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study). (France, 1st page, 2019) https://journals.lww.com/eurojgh/Citation/2019/02000/No_influence_of_cannabis_use_on_liver_stiffness_in.21.aspx
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution TherapyData From the German Hepatitis C-Registry (DHC-R). (Germany, full, 2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440029/
Medical Marijuana For Viral Hepatitis. (news – 2019)
https://www.marijuanadoctors.com/conditions/viral-hepatitis/
Weed and Liver Disease: Where Does the Science Stand? (news – 2019)
https://www.labroots.com/trending/cannabis-sciences/14289/weed-and-liver-disease-science
Medical Cannabis Can Help You Heal From Hepatitis C. (news – 2019)
https://thefreshtoast.com/cannabis/medical-cannabis-can-help-you-heal-from-hepatitis-c/
2018
Use of cannabis and risk of advanced liver fibrosis in patients with chronic hepatitis C virus infection: A systematic review and meta-analysis. (USA/ Thailand, PDF, 2018) https://www.researchgate.net/publication/328764449_Use_of_cannabis_and_risk_of_advanced_liver_fibrosis_in_patients_with_chronic_hepatitis_C_virus_infection_A_systematic_review_and_meta-analysis
Marijuana is not associated with progression of hepatic fibrosis in liver disease: a systematic review and meta-analysis. (USA, PDF, 2018) https://www.researchgate.net/publication/327798677_Marijuana_is_not_associated_with_progression_of_hepatic_fibrosis_in_liver_disease_a_systematic_review_and_meta-analysis
Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. (France, full, 2018) https://www.tandfonline.com/doi/full/10.1080/14787210.2018.1473764
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis. (USA/ Canada, full, 2018) https://www.hindawi.com/journals/cjgh/2018/9430953/
Hepatitis A virus infection associated with cannabis use. (Canada, full, 2018) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764743/
2017
Hepatic expressions of cannabinoid receptors CB1 and CB2 correlate with the fibrogenesis in patients with chronic hepatitis B. (China, full, 2017) https://www.ijidonline.com/article/S1201-9712(17)30091-7/fulltext
Immunoregulatory Role of Cannabinoids during Infectious Disease. (Mexico, full, 2017) https://www.karger.com/Article/FullText/481824
Potential of Cannabidiol for the Treatment of Viral Hepatitis. (Jamaica/ USA, full, 2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330095/
2016
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women. (USA/ Canada, full, 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967608/
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. (Germany, full, 2016) https://www.oncotarget.com/article/7950/
2015
Effects of cannabinoids and their receptors on viral infections. (Iran/ Poland, PDF, 2015) https://www.researchgate.net/publication/277959441_Effects_of_cannabinoids_and_their_receptors_on_viral_infections_The_Cannabinoids_and_Viral_Infection
The impact of the CB2-63 polymorphism on the histological presentation of chronic hepatitis B. (Italy, full, 2015) https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(15)00313-4/fulltext
Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation. (Switzerland/ Germany, full, 2015) https://www.mdpi.com/1422-0067/16/4/7057/htm
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. (USA, full, 2015) https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes. (Canada, full, 2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144456/
Restoring homeostasis of CD4(+) T cells in hepatitis-B-virus-related liver fibrosis. (China, full, 2015) https://www.wjgnet.com/1007-9327/full/v21/i38/10721.htm
2014
Report on Medical Cannabis Research History- What the Science Says. (article – 2014)
https://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
2013
Medical Update: New Perspective on Marijuana for Hepatitis C. (news – 2013)
https://www.hepatitiscentral.com/news/news-update-new-perspective-on-marijuana-for-hepatitis-c/
2011
Cannabis Compound Induces Death Of Cells Associated With Liver Fibrosis (news–2011) http://norml.org/news/2011/06/30/cannabis-compound-induces-death-of-cells-associated-with-liver-fibrosis